Phenotypic characterization and anti-tumor effects of cytokine-induced killer cells derived from cord blood

CB-CIK cells exhibit more efficient anti-tumor activity in in vitro analysis and in the preclinical model and may serve as a potential therapeutic approach for the treatment of cancer.